NASDAQ:GILDGilead Sciences Competitors & Alternatives

$74.92

+1.74 (+2.38 %)

(As of 05/27/2020 04:00 PM ET)

Add

Compare

Today's Range

$72.38

Now: $74.92▼

$74.98

50-Day Range

$72.34

MA: $77.43▼

$84.00

52-Week Range

$60.89

Now: $74.92▼

$85.97

Volume11.74 million shs

Average Volume20.20 million shs

Market Capitalization$93.98 billion

P/E Ratio19.26

Dividend Yield3.72%

Beta0.72

Gilead Sciences (NASDAQ:GILD) Competitors and Alternatives

The following companies in the sub-industry of "biotechnology" are considered alternatives and competitors to Gilead Sciences.

Competitor Name	Beat the Market Rank	Current Price	Price Change	Market Cap	Revenue	P/E Ratio	Indicator(s)
AMGN Amgen	2.3	$224.81	+1.1%	$130.83 billion	$23.36 billion	17.62	Analyst Downgrade
CELG Celgene	1.7	$108.24	+0.0%	$77.04 billion	$15.28 billion	14.22
VRTX Vertex Pharmaceuticals	1.4	$278.51	+4.3%	$68.56 billion	$4.16 billion	48.27
REGN Regeneron Pharmaceuticals	1.4	$544.01	+0.2%	$62.70 billion	$7.86 billion	27.34	Analyst Report Insider Selling High Trading Volume
BIIB Biogen	1.7	$301.46	+1.9%	$47.94 billion	$14.38 billion	9.30
SGEN Seattle Genetics	1.3	$152.97	+0.8%	$26.96 billion	$916.71 million	-81.37	Analyst Upgrade
ALXN Alexion Pharmaceuticals	2.9	$106.14	+3.1%	$22.41 billion	$4.99 billion	9.99	Analyst Report
INCY Incyte	1.4	$98.22	+0.5%	$21.13 billion	$2.16 billion	-56.13	Analyst Downgrade Unusual Options Activity
BMRN BioMarin Pharmaceutical	1.7	$106.70	+2.8%	$18.90 billion	$1.70 billion	174.92	Unusual Options Activity
ALNY Alnylam Pharmaceuticals	1.7	$133.35	+2.3%	$16.13 billion	$219.75 million	-16.61

EXAS EXACT Sciences	1.8	$82.11	+1.6%	$11.80 billion	$876.29 million	-105.27
NBIX Neurocrine Biosciences	1.8	$119.11	+0.2%	$11.04 billion	$788.10 million	64.73
IMMU Immunomedics	1.9	$34.17	+0.2%	$7.61 billion	$290,000.00	-18.67
IONS Ionis Pharmaceuticals	1.6	$56.12	+0.1%	$7.58 billion	$1.12 billion	51.02
EXEL Exelixis	1.8	$24.40	+0.3%	$7.46 billion	$967.78 million	26.24	Insider Selling
RGEN Repligen	1.2	$128.07	+4.1%	$7.30 billion	$270.24 million	284.61	Analyst Report Insider Selling
UTHR United Therapeutics	1.3	$116.81	+1.4%	$5.17 billion	$1.45 billion	9.74
EBS Emergent Biosolutions	1.4	$84.13	+0.1%	$4.43 billion	$1.11 billion	64.72	Analyst Downgrade
MNTA Momenta Pharmaceuticals	1.2	$32.59	+2.7%	$3.91 billion	$23.87 million	-11.64	Analyst Report
CCXI ChemoCentryx	1.5	$63.14	+6.2%	$3.73 billion	$36.13 million	-57.93	Analyst Report Insider Selling
FOLD Amicus Therapeutics	1.4	$12.45	+2.2%	$3.27 billion	$182.24 million	-9.58
HALO Halozyme Therapeutics	2.2	$23.98	+1.4%	$3.23 billion	$195.99 million	-43.60
ARNA Arena Pharmaceuticals	1.5	$58.14	+2.1%	$2.97 billion	$806.43 million	-9.00	Insider Selling
NVAX Novavax	1.2	$45.47	+5.9%	$2.67 billion	$18.66 million	-10.98	Analyst Report
ALKS Alkermes	1.7	$16.74	+3.5%	$2.54 billion	$1.17 billion	-19.02
ICPT Intercept Pharmaceuticals	1.8	$74.43	+2.7%	$2.52 billion	$252 million	-6.94
MDGL Madrigal Pharmaceuticals	1.6	$120.00	+0.4%	$1.94 billion	N/A	-17.62
IRWD Ironwood Pharmaceuticals	1.4	$10.65	+9.9%	$1.91 billion	$428.41 million	20.09	High Trading Volume Heavy News Reporting
LGND Ligand Pharmaceuticals	1.4	$104.77	+1.0%	$1.61 billion	$120.28 million	-30.46
SGMO Sangamo Therapeutics	1.6	$11.44	+4.5%	$1.52 billion	$102.43 million	-13.78
OPK Opko Health	2.3	$2.29	+0.9%	$1.51 billion	$901.90 million	-4.77	Analyst Downgrade Insider Buying
INVA Innoviva	1.5	$14.60	+3.1%	$1.44 billion	$261.02 million	8.54
MYGN Myriad Genetics	1.5	$14.59	+2.3%	$1.06 billion	$851.10 million	-7.30
IMGN ImmunoGen	1.4	$4.86	+0.2%	$835.42 million	$82.27 million	-8.38
BCRX BioCryst Pharmaceuticals	1.5	$5.04	+3.4%	$802.10 million	$48.83 million	-5.36
CDXS Codexis	1.5	$12.30	+0.4%	$722.41 million	$68.46 million	-49.20
MTEM Molecular Templates	1.6	$15.89	+1.6%	$710.79 million	$22.27 million	-7.32
ZIOP ZIOPHARM Oncology	1.4	$3.49	+6.6%	$698.59 million	$150,000.00	-4.99
VNDA Vanda Pharmaceuticals	2.0	$11.12	+0.4%	$600.05 million	$227.19 million	5.20	Analyst Upgrade
CLVS Clovis Oncology	1.6	$6.88	+0.0%	$529.07 million	$143.01 million	-0.96
NLNK NewLink Genetics	0.6	N/A	N/A	$505.05 million	$940,000.00	-12.26
DVAX Dynavax Technologies	1.5	$4.94	+5.5%	$455.37 million	$35.22 million	-2.68	Analyst Downgrade
AGEN Agenus	1.6	$2.75	+7.6%	$433.51 million	$150.05 million	-2.22	High Trading Volume
BSTC BioSpecifics Technologies	1.9	$61.20	+2.8%	$425.05 million	$38.19 million	18.38
PDLI PDL BioPharma	1.2	$3.32	+0.3%	$385.77 million	$54.76 million	-3.53	Analyst Upgrade
SPPI Spectrum Pharmaceuticals	1.5	$3.01	+0.7%	$359.89 million	$109.33 million	-2.51	Analyst Downgrade
PGNX Progenics Pharmaceuticals	1.4	$4.29	+8.2%	$342.92 million	$34.99 million	-5.57
RIGL Rigel Pharmaceuticals	1.5	$2.04	+2.9%	$333.77 million	$59.29 million	-12.75	Analyst Report
GERN Geron	1.4	$1.64	+3.0%	$324.58 million	$460,000.00	-4.56
MNKD MannKind	1.3	$1.52	+2.0%	$317.58 million	$63.04 million	-6.61